Effects of all-trans-retinoic on human gastric cancer cells BGC-823

Journal of Digestive Diseases

Volumn 8, Issue 1, 2007, Pages 29-34

  Zhang, Jin Ping ^a   Chen, Xiang Yu ^a   Li, Jian Sheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Cell growth; Gastric cancer cell; Vascular endothelial growth factor

Indexed keywords

EID: 84876020726     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2007.00280.x     Document Type: Article

References (43)

1. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004; 328: 1-16.
2. Vasios GW, Gold JD, Petkovich M, Chambon P, Gudas LJ. A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene. Proc Natl Acad Sci USA 1989; 86: 9099-103.
3. Naar AM, Boutin JM, Lipkin SM et al. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 1991; 65: 1267-79.
4. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255-66.
5. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3: 513-26.
6. Liu Y, Lee MO, Wang HG et al. Retinoic acid receptor mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996; 16: 1138-49.
7. Zheng A, Mantymaa P, Saily M, Savolainen E, Vahakangas K, Koistinen P. p53 pathway in apoptosis induced by all trans-retinoic acid in acute myeloblastic leukaemia cells. Acta Haematol 2000; 103: 135-43.
8. Wan YJ, Cai Y, Cowan C, Magee TR. Fatty acyl-CoAs inhibit retinoic acid-induced apoptosis in Hep3B cells. Cancer Letter 2000; 154: 19-27.
9. Manna SK, Aggarwal BB. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells. Oncogene 2000; 19: 2110-9.
10. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70.
11. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-6.
12. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32A: 2413-22.
13. Damert A, Miquerol L, Gertsenstein M, Risau W, Nagy A. Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 2002; 129: 1881-92.
14. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
15. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
16. Isner JM, Losordo DW. Therapeutic angiogenesis for heart failure. Nat Med 1999; 5: 491-2.
17. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001; 49: 568-81.
18. Keck PJ, Hauser SD, Krivi G et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
19. Neufeld G, Kessler O, Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 2002; 515: 81-90.
20. Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem Soc Trans 2003; 31: 20-4.
21. Dias S, Hattori K, Heissig B et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001; 98: 10857-62.
22. Broggini M, Marchini SV, Galliera E et al. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4. Leukemia 2003; 17: 52-9.
23. Narendran A, Ganjavi H, Morson N et al. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth. Exp Hematol 2003; 31: 693-701.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
25. Zhang YL, Wang SY, Peng XX. Identification of a type of human IgG-like protein in shrimp Penaeus vannamei by mass spectrometry. J Exp Biol Ecol 2004; 301: 39-54.
26. Tallman MS. New agents for the treatment of acute myeloid leukemia. Best Pract Res Clin Haematol 2006; 19: 311-20.
27. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr 2004; 24: 201-21.
28. Dimberg A, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 2003; 44: 1641-50.
29. Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ. All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res 1997; 232: 277-86.
30. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential downregulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27 (Kip1). Blood 2002; 99: 2199-206.
31. Nakagawa S, Fujii T, Yokoyama G, Kazanietz MG, Yamana H, Shirouzu K. Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: involvement of protein kinase C a and extracellular signal-regulated kinase mitogen-activated protein kinase. Mol Carcinog 2003; 38: 106-16.
32. Simeone AM, Tari AM. How retinoids regulate breast cancer cell proliferation and apoptosis. Cell Mol Life Sci 2004; 61: 1475-84.
33. Risau W, Drexler H, Mironov V et al. Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992; 7: 261-6.
34. Arnold F, West DC. Angiogenesis in wound healing. Pharmacol Ther 1991; 52: 407-22.
35. Welsh AO, Enders AC. Chorioallantoic placenta formation in the rat, II: angiogenesis and maternal blood circulation in the mesometrial region of the implantation chamber prior to placenta formation. Am J Anat 1991; 192: 347-65.
36. Rogers PA, Abberton KM, Susil B. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Hum Reprod 1992; 7: 1061-6.
37. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia, PA: W.B. Saunders, 1995; 206-32.
38. Wolfgang W, Michael R, Michael M, Erwin T. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J Invest Dermatol 1998; 111: 907-11.
39. Lachgar S, Charveron M, Gall Y, Bonafe JL. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 1999; 199: 125-7.
40. Tee MK, Vigne JL, Taylor RN. All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology 2006; 147: 1264-70.
41. Pa S, Iruela Arispe ML, Harvey VS et al. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Microvasc Res 2000; 60: 112-20.
42. Lingen MW, Polverini PJ, Bouck NP. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest 1996; 74: 476-83.
43. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol 1996; 149: 247-58.